Press Releases
November 18, 2010 - ArterX™ Clinical Trial Results Announced at Veith Meeting
US clinical trial results for Tenaxis' investigational vascular surgical sealant, ArterX, were presented today at the Veith Meeting in New York.
Read more >>
October 22, 2010 - Tenaxis Medical Inc Announces "Fileable" Status of PMA
Tenaxis Medical submitted its PMA to the FDA on July 27, 2010 and has now received confirmation from the FDA that "we have made a threshold determination that the PMA is sufficiently complete to permit a substantive review and is, therefore, suitable for filing."
Read more >>
March 4, 2010 - Tenaxis Medical, Inc. Statement on German Court Nullification of CryoLife, Inc. 'Kowanko' Patent
The German Federal Patent Court in Munich has indicated their intention to nullify the German patent DE 693 31 011 (German Kowanko patent) assigned to CryoLife, Inc. of Kennesaw, GA.
Read more >>
January 25, 2010 - Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study
Tenaxis Medical has completed enrollment of its pivotal US study for the ArterX Vascular Sealant™.
Read more >>
July 2, 2007 - Tenaxis Medical Inc announces first human use of ArterX™ Vascular Sealant
No bleeding at suture sites in first human use of ArterX™ Vascular Sealant.
Read more >>